SF3B1 and myelodysplastic syndrome: Interestingly, by making use of a model of iPS derived from an MDS patient with the SF3B1 mutation, which recapitulates global mis-splicing observed in primary MDS-RS cells, Clough and colleagues gave rise to RS in vitro.